• Claudia Müller-Ladner, Ulf Müller-Ladner, and European League Against Rheumatism.
• Justus-Liebig Universität Giessen, Abt. Rheumatologie und klinische Immunologie, Kerckhoff Klinik Bad Nauheim, Benekestrasse 2, 61231 Bad Nauheim.
• Med Monatsschr Pharm. 2012 Oct 1; 35 (10): 353-64; quiz 365-6.

AbstractSince patients with autoimmune inflammatory rheumatic diseases are prone to infectious complications--on one hand due to the rheumatic disease itself, on the other hand due to the immunosuppressive therapy--vaccination is an essential tool to prevent these infectious complications. Although there exist several recommendations for the vaccination of immunocompromised patients, many questions still remain for the distinct clinical situations of patients with autoimmune inflammatory rheumatic diseases. In addition, there are several questions concerning the safety and efficacy of various vaccinations, especially with regard to live-attenuated vaccines. Therefore, EULAR (European League Against Rheumatism) assembled two expert panels to clarify as much of these clinical problems as possible. After extensive literature review and evidence grading, the expert panels published recommendations for the vaccination of adult and pediatric patients, which are outlined in this review article.

15 keywords...

hide…